3SBio, Inc. (TRSBF)
1.725
0.00 (0.00%)
USD |
OTCM |
Oct 27, 16:00
3SBio Price : 1.725 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 26, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 23, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 22, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 21, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 20, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 500.00 |
| Oct 19, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 16, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 15, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 14, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 13, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 12, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 260.00 |
| Oct 09, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Oct 08, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Oct 07, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 59000.00 |
| Oct 06, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Oct 05, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Oct 02, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Oct 01, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 30, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 29, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 28, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 25, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 24, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
| Sep 23, 2026 | 2.15 | 2.15 | 2.15 | 2.15 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.72 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 2.58 |
Price Related Metrics
| PE Ratio | 3.684 |
| PS Ratio | 1.724 |
| PEG Ratio | 0.0093 |
| Price to Book Value | 27.83 |
| Price to Free Cash Flow | 3.390 |
| Earnings Yield | 27.15% |
| Market Cap | 4.315B |
| PEGY Ratio | 0.0092 |
| Operating PE Ratio | 2.843 |
| Normalized PE Ratio | 3.721 |